Home/Filings/4/0001562180-22-001870
4//SEC Filing

Yoder Stephen S. 4

Accession 0001562180-22-001870

CIK 0001583648other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:44 PM ET

Size

8.9 KB

Accession

0001562180-22-001870

Insider Transaction Report

Form 4
Period: 2022-02-22
Yoder Stephen S.
DirectorCEO and President
Transactions
  • Award

    Stock Option (Right to buy)

    2022-02-22+625,874625,874 total
    Exercise: $3.03Exp: 2032-02-22Common Stock (625,874 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the option shares on February 22, 2023 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.

Issuer

PIERIS PHARMACEUTICALS, INC.

CIK 0001583648

Entity typeother

Related Parties

1
  • filerCIK 0001645577

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:44 PM ET
Size
8.9 KB